Winquist A G, Roome A, Hadler J
Epidemic Intelligence Service, Epidemiology Program Office, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Pediatrics. 2001 Jan;107(1):67-72. doi: 10.1542/peds.107.1.67.
Varicella can result in severe, persistent, or recurrent disease in human immunodeficiency virus (HIV)-infected children. In the summer of 1997, we were notified of a suspected varicella outbreak among attendees of a summer camp for HIV-infected children. We investigated this outbreak to determine the extent and sequelae of the outbreak, and to identify factors that contributed to the outbreak to identify measures for preventing such outbreaks at the camp in the future.
To identify varicella-susceptible persons and those developing varicella after camp and to evaluate the camp's varicella prevention measures, we reviewed camp records for the 110 campers and 96 staff at the implicated camp session, mailed questionnaires to the campers' parents/guardians and physicians, and interviewed susceptible staff. We defined a case as varicella in a person who attended the session with onset </=21 days after the session ended.
Eleven of 31 susceptible children (36%) and 2 of 4 susceptible adults developed varicella. Two children were hospitalized. One developed cellulitis. Cases occurred among children in 5 of 15 cabins. The most likely index case was a child with active zoster at camp, reported to the camp after the session ended. The camp had varicella-prevention measures in place, but the varicella-susceptibility and exposure information provided to the camp was often incomplete or inaccurate. Staff with no varicella history underwent serologic testing, but susceptible staff members were not vaccinated.
Widespread varicella transmission occurred at the camp. A case of zoster was the most likely source. The risk for such outbreaks can be minimized through vaccinating susceptible staff members, considering vaccination for asymptomatic or mildly symptomatic HIV-infected children according to Advisory Committee on Immunization Practices and American Academy of Pediatrics guidelines, rigorously collecting recent varicella and zoster exposure information, excluding anyone with active varicella or zoster or with recent varicella or zoster exposure, and considering varicella and zoster exposures at camp to be potentially camp-wide.varicella, human immunodeficiency virus infections, disease outbreaks, intravenous immunoglobulin.
水痘可导致感染人类免疫缺陷病毒(HIV)的儿童出现严重、持续或复发性疾病。1997年夏天,我们接到通知,一所HIV感染儿童夏令营的参与者中疑似发生水痘暴发。我们对此次暴发进行调查,以确定暴发的范围和后果,并找出导致暴发的因素,从而确定未来在该营地预防此类暴发的措施。
为了确定对水痘易感的人员以及在夏令营结束后发生水痘的人员,并评估该营地的水痘预防措施,我们查阅了相关夏令营时段110名营员和96名工作人员的营地记录,向营员的父母/监护人及医生邮寄了调查问卷,并对易感工作人员进行了访谈。我们将病例定义为在参加该时段夏令营且在时段结束后≤21天内发病的水痘患者。
31名易感儿童中有11名(36%)以及4名易感成人中有2名发生了水痘。两名儿童住院治疗。一名儿童发生了蜂窝织炎。15个小屋中有5个小屋的儿童出现了病例。最可能的首例病例是一名在营地患活动性带状疱疹的儿童,在时段结束后才报告给营地。该营地有水痘预防措施,但提供给营地的水痘易感性和暴露信息往往不完整或不准确。无水痘病史的工作人员接受了血清学检测,但易感工作人员未接种疫苗。
该营地发生了水痘的广泛传播。一例带状疱疹很可能是传染源。通过以下措施可将此类暴发的风险降至最低:为易感工作人员接种疫苗;根据免疫实践咨询委员会和美国儿科学会的指南,考虑为无症状或症状轻微的HIV感染儿童接种疫苗;严格收集近期水痘和带状疱疹暴露信息;排除任何患有活动性水痘或带状疱疹或近期有过水痘或带状疱疹暴露的人员;并将营地内的水痘和带状疱疹暴露视为可能涉及整个营地的情况。水痘、人类免疫缺陷病毒感染、疾病暴发、静脉注射免疫球蛋白